263 related articles for article (PubMed ID: 4595319)
1. Immunoprophylaxis of malignant melanoma with systemic BCG: study of strain, dose, and schedule.
Gutterman JU; Mavligit G; McBride C; Frei E; Hersh EM
Natl Cancer Inst Monogr; 1973 Dec; 39():205-12. PubMed ID: 4595319
[No Abstract] [Full Text] [Related]
2. Experience with BCG adjuvant immunotherapy in stage II malignant melanoma.
Peter HH; Deutschmann EM; Schultheis W; Deicher H
Dev Biol Stand; 1977 Apr 13-15; 38():537-40. PubMed ID: 344106
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy of melanoma with intralesional BCG.
Bornstein RS; Mastrangelo MJ; Sulit H; Chee D; Yarbro JW; Prehn LM; Prehn RT
Natl Cancer Inst Monogr; 1973 Dec; 39():213-20. PubMed ID: 4595320
[No Abstract] [Full Text] [Related]
4. In vitro assay of cell-mediated immunity in BCG therapy of malignant melanoma: a preliminary report.
Nathanson L; Clark DA
Natl Cancer Inst Monogr; 1973 Dec; 39():221-4. PubMed ID: 4595321
[No Abstract] [Full Text] [Related]
5. BCG in cancer immunotherapy: results obtained with various BCG preparations in a screening study for systemic adjuvants applicable to cancer immunoprophylaxis or immunotherapy.
Mathé G; Halle-Pannenko O; Bourut C
Natl Cancer Inst Monogr; 1973 Dec; 39():107-13. PubMed ID: 4150738
[No Abstract] [Full Text] [Related]
6. Treatment of malignant melanoma by intratumoral injection of BCG.
Pinsky CM; Hirshaut Y; Oettgen HF
Natl Cancer Inst Monogr; 1973 Dec; 39():225-8. PubMed ID: 4595322
[No Abstract] [Full Text] [Related]
7. Results of administering B.C.G. to patients with melanoma.
Grant RM; Mackie R; Cochran AJ; Murray EL; Hoyle D; Ross C
Lancet; 1974 Nov; 2(7889):1096-100. PubMed ID: 4139404
[No Abstract] [Full Text] [Related]
8. Distant cutaneous granulomas after bacille Calmette-Guérin immunotherapy for malignant melanoma: case for direct infection.
Moff SL; Corey GR; Gottfredsson M
Clin Infect Dis; 1999 Dec; 29(6):1569-70. PubMed ID: 10585816
[No Abstract] [Full Text] [Related]
9. Adjuvant immunostimulation in malignant melanoma with oral Bacille Calmette-Guérin.
MacGregor AB; Falk RE; Landi S; Ambus U; Samuel ES; Langer B
Can J Surg; 1977 Jan; 20(1):25-30. PubMed ID: 832200
[TBL] [Abstract][Full Text] [Related]
10. BCG immunotherapy of a mucous membrane malignant melanoma. Report of a case.
Pliskin ME; Mastrangelo MJ; Bellet R; Berkelhammer J
Oral Surg Oral Med Oral Pathol; 1976 Jul; 42(1):73-9. PubMed ID: 781579
[No Abstract] [Full Text] [Related]
11. [Immunotherapy with BCG as coadjuvant in the management of malignant melanomas].
Céspedes de Gómez MM; Aguilar Velázquez G; Valles de Cortés Y
Alergia; 1980 Apr; 27(2):69-86. PubMed ID: 7416444
[No Abstract] [Full Text] [Related]
12. Immunotherapy in malignant melanomaa.
Homes EC; Morton DL; Eilber FR; Golub SE; Sulit HL
Natl Cancer Inst Monogr; 1976 Nov; 44():85-6. PubMed ID: 799763
[TBL] [Abstract][Full Text] [Related]
13. [Immunoreactivity in patients with surgically removed melanoma in the course of BCG vaccination (author's transl)].
Lochman I; Kyselá T; Machálek J; Lochmanová A; Beska F
Cesk Dermatol; 1980; 55(6):372-7. PubMed ID: 7460040
[No Abstract] [Full Text] [Related]
14. [BCG-treatment of malignant melanoma].
Borberg H
Internist (Berl); 1975 Oct; 16(10):482-5. PubMed ID: 1107254
[No Abstract] [Full Text] [Related]
15. [Immunological aspects of melanoma].
Sjögren H
Lakartidningen; 1976 Feb; 73(7):528-30. PubMed ID: 1250045
[No Abstract] [Full Text] [Related]
16. Immunotherapy of human malignant melanoma with oil-attached BCG cell-wall skeleton.
Yamamura Y; Yoshizaki K; Azuma I; Yagura T; Watanabe T
Gan; 1975 Aug; 66(4):355-63. PubMed ID: 1102379
[TBL] [Abstract][Full Text] [Related]
17. Delayed cutaneous sensitivity reactions to extracts of autologous malignant melanoma: a second look.
Bluming AZ; Vogel CL; Ziegler JL; Kiryabwire JW
J Natl Cancer Inst; 1972 Jan; 48(1):17-24. PubMed ID: 4652371
[No Abstract] [Full Text] [Related]
18. [Multidisciplinary treatment of malignant melanoma of the nose and paranasal sinuses--with special reference to oral administration of enterosoluble BCG capsules].
Saito H; Hozawa J; Takagi A; Fukuoka K; Nozawa I; Kamimura T
Gan To Kagaku Ryoho; 1982 Sep; 9(9):1555-61. PubMed ID: 6191718
[TBL] [Abstract][Full Text] [Related]
19. [Immunologic reactions in malignant melanoma of the skin in man].
Veresova OV; Korosteleva TA
Vopr Onkol; 1975; 21(4):74-80. PubMed ID: 1105967
[No Abstract] [Full Text] [Related]
20. Adjuvant treatment of cancer. III. Malignant melanoma.
Lundy J
Conn Med; 1978 Apr; 42(4):220-2. PubMed ID: 639504
[No Abstract] [Full Text] [Related]
[Next] [New Search]
